Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015)-Reference-Cited by-同舟云学术

Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015)

Published:2017-01-10 Issue:4 Volume:27 Page:401-414
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Ivanenkov Yan A.¹²³,Aladinskiy Vladimir A.¹,Bushkov Nikolay A.¹,Ayginin Andrey A.¹,Majouga Alexander G.³,Ivachtchenko Alexandre V.²

Affiliation:

1. Department of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Dolgoprudny City, Moscow Region, Russia

2. Department of Computational and Medicinal Chemistry, ChemDiv, San Diego, CA, USA

3. Chemistry Department, Moscow State University, Moscow, Russia

Funder

Russian Scientific Fund

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1272573

Reference109 articles.

1. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

2. Approved Antiviral Drugs over the Past 50 Years

3. World Health Organization. Hepatitis C WHO fact sheet no. 164. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs164_apr2014/en/

4. Extrahepatic manifestations of chronic hepatitis C virus infection

5. Center for Disease Control and Prevention. Hepatitis C information. Available from: http://www.cdc.gov/hepatitis/hcv

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches;International Journal of Molecular Sciences;2024-08-29

2. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials;Arabian Journal of Chemistry;2023-08

3. Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors;Pharmaceuticals;2022-05-20

4. Deep inverse reinforcement learning for structural evolution of small molecules;Briefings in Bioinformatics;2020-12-22

5. A review on HCV inhibitors: Significance of non-structural polyproteins;European Journal of Medicinal Chemistry;2019-02